Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A re...
Dr Prateek Jain - Tata Medical Center, Kolkata, India
Giving abatacept after checkpoint inhibitors can improve immunotherapy responses...
Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA
Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refrac...
Dr Iván Márquez-Rodas - Hospital General Universitario Gregorio Marañón, Madrid,...
OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO
Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Fr...
OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla...
Significance of gut microbiota in patients receiving CAR T cell immunotherapy
Prof Marco Ruella - University of Pennsylvania, Philadelphia, USA
Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal...
Dr Akhil Kapoor - Tata Memorial Hospital, Mumbai, India
KEYNOTE-716: Adjuvant pembrolizumab prolongs recurrence-free survival in resecte...
Dr Jason Luke - UPMC Hillman Cancer Center, Pittsburgh, USA
ESMO President: What to watch for at ESMO 2021
Prof Solange Peters - ESMO President
Vaccinations in myeloma patients including for COVID-19
Prof Heinz Ludwig - Wilhelminen Cancer Research Institute, Vienna, Austria
PrE0807: Neoadjuvant nivolumab without or with lirilumab in cisplatin-ineligible...
Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA
CheckMate067 outcomes: Nivolumab plus ipilimumab in advanced melanoma
Dr Jedd Wolchok - Memorial Sloan Kettering Center, New York, USA